< Back to Article
Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer
Figure 4
The protein level of galectin-3 was reduced after shRNA treatment.
Three independent shRNAs against galectin-3 were used to construct stable cell lines.
doi: https://doi.org/10.1371/journal.pone.0103482.g004